PDS BIOTECHNOLOGY CORP
PDSB · NASDAQ
Updated at 2026-10-13 15:12:17
- Today's High
- $1.72
- Today’s Low
- $1.39
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.48
- Previous Close
- $1.52
- Volume
- 15.07M
- Market Cap
- $85.07M
- P/E Ratio
- --
- EPS
- $-0.64
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, UNITED STATES, 08540
- Country
- US
- Listing Date
- 2015-10-01
- Fiscal Year End
- December
- Shares Outstanding
- 55.92M
- CIK
- 0001472091
- Website
- www.pdsbiotech.com
PDS Biotechnology Corporation, a clinical-phase biopharmaceutical company, is focused on developing multifunctional cancer immunotherapies. The company is headquartered in Florham Park, New Jersey.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$6.49M
2026-03-31
$6.52M
2025-12-31
$6.67M
2025-09-30
$8.14M
Net Income
2026-06-30
-$9.75M
2026-03-31
-$7.34M
2025-12-31
-$7.56M
2025-09-30
-$9M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.18
2026-03-31
$-0.13
2025-12-31
$-0.14
2025-09-30
$-0.19
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$6.48M
2026-03-31
-$6.31M
2025-12-31
-$6.44M
2025-09-30
-$7.85M
Effective Tax Rate
2026-06-30
--
2026-03-31
--
2025-12-31
-30.93%
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $6.49M | $6.52M | $6.67M | $8.14M |
| Net Income | -$9.75M | -$7.34M | -$7.56M | -$9M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.18 | $-0.13 | $-0.14 | $-0.19 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$6.48M | -$6.31M | -$6.44M | -$7.85M |
| Effective Tax Rate | -- | -- | -30.93% | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.